CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Smoking Cessation Aids for Patients in Treatment for Substance Abuse: Clinical Effectiveness, Cost-Effectiveness and Guidelines

Last updated: August 20, 2015
Project Number: RB0902-000
Product Line: Rapid Response
Research Type: Drug
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical effectiveness of smoking cessation aids for patients starting detoxification or treatment for substance abuse?
  2. What is the cost-effectiveness of smoking cessation aids for patients starting detoxification or treatment for substance abuse?
  3. What are the evidence-based guidelines regarding smoking cessation and for the use of smoking cessation aids in patients starting detoxification or treatment for substance abuse?

Key Message

One systematic review, five randomized controlled trials, and three non-randomized studies were identified regarding the clinical effectiveness of smoking cessation aids for patients starting detoxification or treatment for substance abuse. Additionally, one evidence-based guideline was identified regarding smoking cessation and for the use of smoking cessation aids in patients starting detoxification or treatment for substance abuse.